Grown Rogue International (GRUSF) Beginning Cash Balance (2018 - 2025)

Grown Rogue International (GRUSF) recorded quarterly Beginning Cash Balance of $717.0 billion in Q3 2025, up 186.78% quarter-over-quarter from $250.0 billion in Q3 2024, and up 186.78% on a YoY basis from $250.0 billion in Q3 2024.

Grown Rogue International (GRUSF) Beginning Cash Balance (2018 - 2025) Analysis & Trends

Grown Rogue International's Beginning Cash Balance history runs 5 years deep, the most recent figure standing at $717.0 billion for Q3 2025.

  • In Q3 2025, Beginning Cash Balance rose 186.78% year-over-year to $717.0 billion; the TTM figure through Sep 2025 stood at $967.0 billion (up 286.78% YoY), while the FY2019 annual figure was $826643.0, up 82.4% from the prior year.
  • Beginning Cash Balance was $717.0 billion for Q3 2025 at Grown Rogue International, up from $250.0 billion in the prior quarter.
  • In the past five years, Beginning Cash Balance ranged from a high of $717.0 billion in Q3 2025 to a low of $250.0 billion in Q3 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Grown Rogue International - - 3.96 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 716.96 Bn
Sep 30, 2025 716.96 Bn
Sep 30, 2024 250.00 Bn
Sep 30, 2024 250.00 Bn
Jan 31, 2020 74,926.00
Jan 31, 2020 74,926.00
Jan 31, 2019 826,643.00
Jan 31, 2019 826,643.00
Jan 31, 2018 453,199.00
Jan 31, 2018 453,199.00